Smart Inhalers Market Report 2026

Smart Inhalers Market Overview

• Smart Inhalers market size has reached to $1.8 billion in 2025 • Expected to grow to $2.88 billion in 2030 at a compound annual growth rate (CAGR) of 9.8% • Growth Driver: The Impact Of Rising Chronic Respiratory Diseases On The Smart Inhalers Market • Market Trend: Advancements In Universal Inhaler Dose Counters To Improve Medication Adherence And Patient Monitoring • North America was the largest region in 2025.

What Is Covered Under Smart Inhalers Market?

Smart inhalers refer to medical devices that integrate connectivity with a mobile app, typically via Bluetooth. It is used to enhance the user experience and provide more personalized treatment decisions for individuals with chronic lung conditions such as asthma and chronic obstructive pulmonary disease (COPD). The main types of smart inhalers are dry powdered inhalers (DPIs) and metered dose inhalers (MDIs). Dry powdered inhalers (DPIs) are a type of inhaler used to deliver medications, such as inhaled corticosteroids, into the lungs. They are used in the treatment of various indications, such as asthma, chronic obstructive pulmonary disease (COPD), and others, and are distributed through several distribution channels, including hospital pharmacies, retail pharmacies, and online pharmacies. These are used by various end-users, such as hospitals, homecare settings, and others.

What Is The Smart Inhalers Market Growth Forecast?

The smart inhalers market size is expected to see strong growth in the next few years. It will grow to $2.88 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to remote patient monitoring growth, expansion of value-based care, smartphone health app usage, regulatory approvals, pediatric asthma management focus. Major trends in the forecast period include integration of usage tracking sensors, growth of app-connected inhalers, expansion of asthma management platforms, adoption of real-time adherence alerts, increased payer support.

Global Smart Inhalers Market Segmentation

1) By Type: Dry Powdered Inhalers (DPIs), Metered Dose Inhalers (MDIs) 2) By Indication: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Other Indications 3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies 4) By End-User: Hospitals, Homecare Settings, Other End-Users Subsegments: 1) By Dry Powdered Inhalers (DPIs): Single-Dose DPIs, Multi-Dose DPIs 2) By Metered Dose Inhalers (MDIs): Digitally Enabled MDIs, Smart MDIs With Connectivity Features

What Is The Driver Of The Smart Inhalers Market?

The rising prevalence of chronic respiratory diseases (CRDs) is expected to boost the growth of the smart inhaler market going forward. Chronic respiratory diseases (CRDs) encompass a range of long-term conditions that affect the airways and other structures of the lungs. Smart inhalers, by tracking usage and offering reminders for missed doses, manage chronic respiratory diseases such as asthma and COPD, ensuring consistent medication use for symptom control and prevention of exacerbations. For instance, in December 2023, according to the National Center for Biotechnology Information, a US-based government agency, the number of COPD cases was expected to rise by 112 million, reaching a total of 592 million by 2050, which would represent 9.5% of the eligible population. Therefore, the rising prevalence of chronic respiratory diseases (CRDs) is driving the growth of the smart inhaler industry.

Key Players In The Global Smart Inhalers Market

Major companies operating in the smart inhalers market are Novartis AG, AstraZeneca Plc, GlaxoSmithKline Plc, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Lupin Limited, Aptar Group Inc., Nemera France SAS, Vectura Group Limited, Propeller Health, Findair Sp.z o.o., Biocorp Production, Cohero Health Inc., Pneuma Respiratory Inc., Amiko Digital Health Limited, AireHealth Inc., Adherium Ltd., Zeolr Technologies Pvt Ltd., H&T Presspart Manufacturing Ltd., Cognita Labs LLC, Teva Respiratory LLC, AstraZeneca Respiratory Devices

Global Smart Inhalers Market Trends and Insights

Major companies operating in the smart inhaler market are focusing on developing technological advancements such as universal dose counters and connected inhaler systems to enhance medication adherence, usability, and patient monitoring. Universal dose counters are devices that attach to various inhaler types to accurately track the number of doses taken, improving medication adherence and monitoring. For instance, in June 2024, Aseptika, a UK-based digital health company, launched the PUFFClicker3 universal inhaler dose counter. The device is designed to fit a wide range of inhalers, providing accurate dose tracking, improving adherence, and enabling remote monitoring of inhaler use for patients with respiratory conditions such as asthma and COPD. By integrating easy-to-read counters and digital tracking, PUFFClicker3 aims to enhance patient outcomes and support healthcare providers in managing chronic respiratory diseases more effectively.

What Are Latest Mergers And Acquisitions In The Smart Inhalers Market?

In December 2024, Adherium Ltd., a Australia-based digital health company, formed a partnership with Tenovi to advance remote patient monitoring solutions for respiratory diseases. The collaboration aims to enhance patient engagement, improve medication adherence, and provide real-time health insights, fostering better disease management and driving innovation in the digital respiratory care market. Tenovi is a US-based technology company specializing in remote monitoring platforms for chronic health conditions.

Regional Outlook

North America was the largest region in the smart inhalers market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Smart Inhalers Market?

The smart inhalers market consists of sales of pressurized MDIs (metered-dose inhalers), breath-actuated MDIs (metered-dose inhalers), and related products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Smart Inhalers Market Report 2026?

The smart inhalers market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the smart inhalers industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.